Trial · NCT04400487
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Total Daily Physical Activity (Counts Per Minute) to Week 10-12 | Voxelotor | -155.6 | Standard Deviation 458.45 | Counts per minute | |
| Change From Baseline in Total Daily Physical Activity (Counts Per Minute) to Week 22-24 | Voxelotor | -79.4 | Standard Deviation 443.77 | Counts per minute | |
| Change From Baseline in Light Physical Activity to Week 10-12 | Voxelotor | 5.8 | Standard Deviation 62.67 | minutes/day | |
| Change From Baseline in Light Physical Activity to Week 22-24 | Voxelotor | -11.7 | Standard Deviation 115.34 | minutes/day | |
| Change From Baseline in Moderate Physical Activity to Week 10-12 | Voxelotor | -9.0 | Standard Deviation 25.55 | minutes/day | |
| Change From Baseline in Moderate Physical Activity to Week 22-24 | Voxelotor | -5.7 | Standard Deviation 30.01 | minutes/day | |
| Change From Baseline in Vigorous Physical Activity to Week 10-12 | Voxelotor | 0.0 | Standard Deviation 4.94 | minutes/day | |
| Change From Baseline in Vigorous Physical Activity to Week 22-24 | Voxelotor | -1.2 | Standard Deviation 6.52 | Minutes/day | |
| Change From Baseline in Total Nocturnal Sleep Time to Week 10-12 | Voxelotor | 0.3 | Standard Deviation 77.64 | Minutes/day | |
| Change From Baseline in Total Nocturnal Sleep Time to Week 22-24 | Voxelotor | 17.6 | Standard Deviation 141.10 | Minutes/day | |
| Change From Baseline in Wake Time After Sleep Onset to Week 10-12 | Voxelotor | 2.0 | Standard Deviation 37.10 | Minutes/day | |
| Change From Baseline in Wake Time After Sleep Onset to Week 22-24 | Voxelotor | 2.0 | Standard Deviation 42.00 | Minutes/day | |
| Percentage of Participants With a More Than (>)1 Grams Per Deciliter (g/dL) Increase in Hemoglobin (Hb) at Week 12 | Voxelotor | 41.7 | Percentage of participants | ||
| Percentage of Participants With a >1 g/dL Increase in Hemoglobin (Hb) at Week 24 | Voxelotor | 26.1 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04400487/results